Voice for 100 million people infected with hepatitis B, what did the movie "Not Stop" convey?
"An intern reporter speaks for the discriminated people." The movie "Not Stop" is being shown. Zhang Songwen, the leading actor, wrote an article on social media, saying that one of the reasons why he tried his best to run a roadshow for this film was that he was moved by the script. The film is adapted from a real event and shows the growth path of a newspaper intern named HanDong (played by Ke Bai) in a first-tier city at the beginning of the 21st century. One of the story lines tells that HanDong tried to change the fate of about 100 million people infected with hepatitis B virus with the help of a news report calling for the elimination of hepatitis B discrimination. Focusing on the profession of journalists and choosing anti-discrimination themes combine to add a little sense of topic to the film. Twenty years later, what changes have been made in the impression of hepatitis B patients? Has discrimination eased? When we look back at that memory, what are our thoughts?
Realism: seeking refuge in the immortal cause
In the film, when a veteran journalist Huang Jiang (decorated by Zhang Songwen) first met Han Dong, he saw such a sentence in his book: "Seek refuge in an immortal career".
This passage from Zweig’s "When the Stars Shine" also reflects the main story of the film: In 2003, when hepatitis B was avoided by the public and kept secret, intern reporter HanDong gradually realized the irrationality of this concept and regulation in an investigation on the physical examination of hepatitis B patients. After fighting with the "blood cow" and constantly struggling in his heart, he chose to approach his "immortal career" — — Write down the report "The Anti-discrimination Proposition of 120 Million People in China" to give voice to the discriminated HBV-infected people.
"I hope to tell a story about a person, a story about a young man growing up." When talking about the original intention of the film, the film director Jing Wong said, "In 2003, the plight of people infected with hepatitis B virus was tracked and reported by media reporters like HanDong, which formed the public opinion thrust of the society and improved some difficulties of hepatitis B groups to some extent."
At the beginning of creation, director Jing Wong had many meetings and exchanges with people infected with hepatitis B virus in Guangzhou. In the in-depth conversation with these "comrades-in-arms of hepatitis B", director Wang Jing had a deep feeling. "I think their living conditions and inner difficulties are not a single group. Although we as ordinary people can’t feel the pressure like them, we will also encounter various difficulties, so I hope that the movie hero can have some connection with these comrades-in-arms."
In order to better show this connection, the director chose to insert and edit the documentary footage of "HanDong Interview with Hepatitis B Patients" in the film, and let the audience feel the connection between themselves and the image in a realistic way.
However, apart from the real performance of the video, the debate about hepatitis B discrimination is still "endless".
After speaking for 100 million people: scientific understanding, elimination of discrimination and active treatment
"In 2003, everyone (HBV-infected people) launched this kind of self-help in the forum, including medical experts and media reporters, and made a lot of efforts. To a certain extent, it has promoted the subsequent introduction of corresponding national policies, including the revision of the Food Safety Law in 2009, which means that people infected with hepatitis B virus can obtain health certificates and work in the food industry. In addition, in 2010, many departments jointly issued a notice, announcing the cancellation of ‘ Five items of hepatitis B ’ Inspection, as shown in the film, the difficulties faced by people infected with hepatitis B virus have been solved to some extent. " Cheng Zhuo, the person in charge of the organization of friends and mutual aid for hepatitis B patients, said.
Cheng Zhuo further stated that the revision and establishment of a number of laws and regulations have reversed the previous general cognition of society, but there is still some discrimination in some remote places, which requires not only the implementation of corresponding policies, but also the joint efforts of all parties to publicize and make the public understand scientifically.
"In fact, there are only three ways of transmission of hepatitis B virus. Mother-to-child, blood and sexual contact transmission, biological contact such as daily life and work will not infect hepatitis B virus, so we don’t need to discriminate against these hepatitis B virus-infected people." Zhuang Hui, an academician of China Academy of Engineering and an epidemiologist, appealed that in the face of hepatitis B, we must first strengthen self-screening, timely vaccination and diagnosis, and if treatment is needed, we can choose active means such as antiviral treatment to prevent the related deaths of liver cirrhosis, liver cancer and even liver disease.
Academician Zhuang introduced that according to the World Health Organization’s Action Plan on AIDS, Viral Hepatitis and Sexually Transmitted Diseases for 2022-2030, by 2030, the diagnosis rate of hepatitis B virus will reach 90% and the treatment rate will reach 80%. At present, the diagnosis rate in China is only 22%, and the treatment rate is 17%, which is still a long way to go.
"At present, we not only need to enhance the awareness of self-screening, but also cultivate the public’s awareness of early treatment. If timely and standardized treatment can be carried out, the incidence of hepatitis B complications can be greatly reduced, so that we can also achieve the goals set by the World Health Organization. " Academician Zhuang explained.
Multi-party cooperation: to eliminate hepatitis B discrimination, "not stop"
"We are not only researching and developing drugs themselves, but also actively cooperating with the national public health work in related diseases and providing support for related public welfare projects to help the public further eliminate incorrect understanding of hepatitis B." Jin Fangqian, global vice president of Gilead Science and general manager of China District, a film public welfare supporter, said that through this cooperation with director Jing Wong, I also hope to help the whole society to further eliminate or reduce hepatitis B discrimination.
Doctors can help patients with clinical treatment, patients’ public welfare mutual aid organizations can unite to speak for themselves, pharmaceutical companies can make diseases treatable, and relevant government departments can make treatment more accessible. These are all behaviors that can produce substantial effects. So what can this movie do? In response to the question that hepatitis B discrimination has been pushed into the public eye again, director Jing Wong replied that he hoped that the film could also provide an opportunity for discussion, just like the title "Not Stop". Even though some things seem to be forgotten, they still exist. "Just like a stone thrown into a pond, we hope to trigger a discussion, and the society will form a joint force to promote change together." (Reporter Zhang Ke, intern reporter Wang Mengyuan)